nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Alkylating Activity—Temozolomide—skin cancer	0.296	0.556	CiPCiCtD
Ifosfamide—germ cell cancer—skin cancer	0.283	1	CtDrD
Ifosfamide—Alkylating Activity—Dacarbazine—skin cancer	0.237	0.444	CiPCiCtD
Ifosfamide—CYP2C8—Vismodegib—skin cancer	0.0181	0.145	CbGbCtD
Ifosfamide—CYP2C19—Vismodegib—skin cancer	0.0152	0.122	CbGbCtD
Ifosfamide—CYP2A6—Fluorouracil—skin cancer	0.013	0.104	CbGbCtD
Ifosfamide—CYP2C9—Vismodegib—skin cancer	0.0126	0.101	CbGbCtD
Ifosfamide—CYP3A4—Temozolomide—skin cancer	0.0106	0.0848	CbGbCtD
Ifosfamide—CYP3A4—Imiquimod—skin cancer	0.0106	0.0848	CbGbCtD
Ifosfamide—CYP3A4—Vismodegib—skin cancer	0.00733	0.0588	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0068	0.0545	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—skin cancer	0.0068	0.0545	CbGbCtD
Ifosfamide—CYP2C8—Fluorouracil—skin cancer	0.00642	0.0515	CbGbCtD
Ifosfamide—CYP3A4—Vemurafenib—skin cancer	0.00579	0.0465	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—skin cancer	0.0051	0.0409	CbGbCtD
Ifosfamide—CYP2C9—Fluorouracil—skin cancer	0.00448	0.0359	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—skin cancer	0.00199	0.0159	CbGbCtD
Ifosfamide—Agranulocytosis—Fluorouracil—skin cancer	5.19e-05	0.000867	CcSEcCtD
Ifosfamide—Ill-defined disorder—Bleomycin—skin cancer	5.19e-05	0.000866	CcSEcCtD
Ifosfamide—Anaemia—Bleomycin—skin cancer	5.17e-05	0.000863	CcSEcCtD
Ifosfamide—Diarrhoea—Vemurafenib—skin cancer	5.15e-05	0.000861	CcSEcCtD
Ifosfamide—Erythema multiforme—Temozolomide—skin cancer	5.12e-05	0.000856	CcSEcCtD
Ifosfamide—Urticaria—Imiquimod—skin cancer	5.1e-05	0.000852	CcSEcCtD
Ifosfamide—Abdominal pain—Imiquimod—skin cancer	5.08e-05	0.000848	CcSEcCtD
Ifosfamide—Body temperature increased—Imiquimod—skin cancer	5.08e-05	0.000848	CcSEcCtD
Ifosfamide—Eye disorder—Temozolomide—skin cancer	5.06e-05	0.000846	CcSEcCtD
Ifosfamide—Tinnitus—Temozolomide—skin cancer	5.05e-05	0.000844	CcSEcCtD
Ifosfamide—Malaise—Bleomycin—skin cancer	5.04e-05	0.000842	CcSEcCtD
Ifosfamide—Flushing—Temozolomide—skin cancer	5.03e-05	0.00084	CcSEcCtD
Ifosfamide—Cardiac disorder—Temozolomide—skin cancer	5.03e-05	0.00084	CcSEcCtD
Ifosfamide—Haemoglobin—Fluorouracil—skin cancer	5.02e-05	0.000838	CcSEcCtD
Ifosfamide—Leukopenia—Bleomycin—skin cancer	5e-05	0.000836	CcSEcCtD
Ifosfamide—Haemorrhage—Fluorouracil—skin cancer	4.99e-05	0.000834	CcSEcCtD
Ifosfamide—Dizziness—Vemurafenib—skin cancer	4.98e-05	0.000832	CcSEcCtD
Ifosfamide—Angiopathy—Temozolomide—skin cancer	4.91e-05	0.000821	CcSEcCtD
Ifosfamide—Immune system disorder—Temozolomide—skin cancer	4.89e-05	0.000817	CcSEcCtD
Ifosfamide—Mediastinal disorder—Temozolomide—skin cancer	4.88e-05	0.000816	CcSEcCtD
Ifosfamide—Cough—Bleomycin—skin cancer	4.88e-05	0.000815	CcSEcCtD
Ifosfamide—Chills—Temozolomide—skin cancer	4.86e-05	0.000812	CcSEcCtD
Ifosfamide—Ill-defined disorder—Dactinomycin—skin cancer	4.84e-05	0.000808	CcSEcCtD
Ifosfamide—Anaemia—Dactinomycin—skin cancer	4.82e-05	0.000805	CcSEcCtD
Ifosfamide—Vomiting—Vemurafenib—skin cancer	4.79e-05	0.0008	CcSEcCtD
Ifosfamide—Alopecia—Temozolomide—skin cancer	4.79e-05	0.0008	CcSEcCtD
Ifosfamide—Chest pain—Bleomycin—skin cancer	4.76e-05	0.000795	CcSEcCtD
Ifosfamide—Myalgia—Bleomycin—skin cancer	4.76e-05	0.000795	CcSEcCtD
Ifosfamide—Rash—Vemurafenib—skin cancer	4.75e-05	0.000793	CcSEcCtD
Ifosfamide—Mental disorder—Temozolomide—skin cancer	4.74e-05	0.000793	CcSEcCtD
Ifosfamide—Dermatitis—Vemurafenib—skin cancer	4.74e-05	0.000792	CcSEcCtD
Ifosfamide—Hypersensitivity—Imiquimod—skin cancer	4.73e-05	0.00079	CcSEcCtD
Ifosfamide—Erythema—Temozolomide—skin cancer	4.71e-05	0.000788	CcSEcCtD
Ifosfamide—Malnutrition—Temozolomide—skin cancer	4.71e-05	0.000788	CcSEcCtD
Ifosfamide—Breast disorder—Docetaxel—skin cancer	4.7e-05	0.000786	CcSEcCtD
Ifosfamide—Discomfort—Bleomycin—skin cancer	4.7e-05	0.000786	CcSEcCtD
Ifosfamide—Malaise—Dactinomycin—skin cancer	4.7e-05	0.000785	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	4.69e-05	0.000783	CcSEcCtD
Ifosfamide—Leukopenia—Dactinomycin—skin cancer	4.67e-05	0.00078	CcSEcCtD
Ifosfamide—Asthenia—Imiquimod—skin cancer	4.61e-05	0.00077	CcSEcCtD
Ifosfamide—Confusional state—Bleomycin—skin cancer	4.6e-05	0.000768	CcSEcCtD
Ifosfamide—Oedema—Bleomycin—skin cancer	4.56e-05	0.000762	CcSEcCtD
Ifosfamide—Anaphylactic shock—Bleomycin—skin cancer	4.56e-05	0.000762	CcSEcCtD
Ifosfamide—Pruritus—Imiquimod—skin cancer	4.54e-05	0.000759	CcSEcCtD
Ifosfamide—Infection—Bleomycin—skin cancer	4.53e-05	0.000757	CcSEcCtD
Ifosfamide—Nausea—Vemurafenib—skin cancer	4.47e-05	0.000747	CcSEcCtD
Ifosfamide—Thrombocytopenia—Bleomycin—skin cancer	4.47e-05	0.000746	CcSEcCtD
Ifosfamide—Arrhythmia—Fluorouracil—skin cancer	4.46e-05	0.000745	CcSEcCtD
Ifosfamide—Vision blurred—Temozolomide—skin cancer	4.44e-05	0.000742	CcSEcCtD
Ifosfamide—Myalgia—Dactinomycin—skin cancer	4.44e-05	0.000741	CcSEcCtD
Ifosfamide—Bronchospasm—Docetaxel—skin cancer	4.43e-05	0.00074	CcSEcCtD
Ifosfamide—Alopecia—Fluorouracil—skin cancer	4.41e-05	0.000737	CcSEcCtD
Ifosfamide—Diarrhoea—Imiquimod—skin cancer	4.39e-05	0.000734	CcSEcCtD
Ifosfamide—Discomfort—Dactinomycin—skin cancer	4.38e-05	0.000733	CcSEcCtD
Ifosfamide—Angina pectoris—Docetaxel—skin cancer	4.38e-05	0.000732	CcSEcCtD
Ifosfamide—Ill-defined disorder—Temozolomide—skin cancer	4.37e-05	0.000731	CcSEcCtD
Ifosfamide—Anaemia—Temozolomide—skin cancer	4.36e-05	0.000728	CcSEcCtD
Ifosfamide—Anorexia—Bleomycin—skin cancer	4.35e-05	0.000726	CcSEcCtD
Ifosfamide—Erythema—Fluorouracil—skin cancer	4.34e-05	0.000726	CcSEcCtD
Ifosfamide—Agitation—Temozolomide—skin cancer	4.33e-05	0.000724	CcSEcCtD
Ifosfamide—Angioedema—Temozolomide—skin cancer	4.31e-05	0.00072	CcSEcCtD
Ifosfamide—Pancytopenia—Docetaxel—skin cancer	4.27e-05	0.000714	CcSEcCtD
Ifosfamide—Hypotension—Bleomycin—skin cancer	4.26e-05	0.000712	CcSEcCtD
Ifosfamide—Oedema—Dactinomycin—skin cancer	4.25e-05	0.000711	CcSEcCtD
Ifosfamide—Malaise—Temozolomide—skin cancer	4.25e-05	0.00071	CcSEcCtD
Ifosfamide—Dizziness—Imiquimod—skin cancer	4.25e-05	0.000709	CcSEcCtD
Ifosfamide—Vertigo—Temozolomide—skin cancer	4.24e-05	0.000708	CcSEcCtD
Ifosfamide—Infection—Dactinomycin—skin cancer	4.23e-05	0.000706	CcSEcCtD
Ifosfamide—Leukopenia—Temozolomide—skin cancer	4.22e-05	0.000705	CcSEcCtD
Ifosfamide—Palpitations—Temozolomide—skin cancer	4.17e-05	0.000696	CcSEcCtD
Ifosfamide—Thrombocytopenia—Dactinomycin—skin cancer	4.17e-05	0.000696	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Bleomycin—skin cancer	4.16e-05	0.000694	CcSEcCtD
Ifosfamide—Cough—Temozolomide—skin cancer	4.11e-05	0.000687	CcSEcCtD
Ifosfamide—Paraesthesia—Bleomycin—skin cancer	4.1e-05	0.000684	CcSEcCtD
Ifosfamide—Vision blurred—Fluorouracil—skin cancer	4.09e-05	0.000684	CcSEcCtD
Ifosfamide—Convulsion—Temozolomide—skin cancer	4.08e-05	0.000683	CcSEcCtD
Ifosfamide—Vomiting—Imiquimod—skin cancer	4.08e-05	0.000682	CcSEcCtD
Ifosfamide—Hypertension—Temozolomide—skin cancer	4.07e-05	0.00068	CcSEcCtD
Ifosfamide—Dyspnoea—Bleomycin—skin cancer	4.07e-05	0.000679	CcSEcCtD
Ifosfamide—Anorexia—Dactinomycin—skin cancer	4.05e-05	0.000678	CcSEcCtD
Ifosfamide—Rash—Imiquimod—skin cancer	4.05e-05	0.000676	CcSEcCtD
Ifosfamide—Dermatitis—Imiquimod—skin cancer	4.04e-05	0.000676	CcSEcCtD
Ifosfamide—Pneumonia—Docetaxel—skin cancer	4.04e-05	0.000674	CcSEcCtD
Ifosfamide—Anaemia—Fluorouracil—skin cancer	4.01e-05	0.000671	CcSEcCtD
Ifosfamide—Myalgia—Temozolomide—skin cancer	4.01e-05	0.000671	CcSEcCtD
Ifosfamide—Arthralgia—Temozolomide—skin cancer	4.01e-05	0.000671	CcSEcCtD
Ifosfamide—Infestation NOS—Docetaxel—skin cancer	4.01e-05	0.00067	CcSEcCtD
Ifosfamide—Infestation—Docetaxel—skin cancer	4.01e-05	0.00067	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	3.99e-05	0.000666	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Docetaxel—skin cancer	3.98e-05	0.000665	CcSEcCtD
Ifosfamide—Discomfort—Temozolomide—skin cancer	3.97e-05	0.000663	CcSEcCtD
Ifosfamide—Decreased appetite—Bleomycin—skin cancer	3.97e-05	0.000663	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Docetaxel—skin cancer	3.95e-05	0.000661	CcSEcCtD
Ifosfamide—Renal failure—Docetaxel—skin cancer	3.94e-05	0.000659	CcSEcCtD
Ifosfamide—Myocardial infarction—Docetaxel—skin cancer	3.93e-05	0.000657	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Docetaxel—skin cancer	3.93e-05	0.000657	CcSEcCtD
Ifosfamide—Stomatitis—Docetaxel—skin cancer	3.91e-05	0.000653	CcSEcCtD
Ifosfamide—Pain—Bleomycin—skin cancer	3.9e-05	0.000652	CcSEcCtD
Ifosfamide—Conjunctivitis—Docetaxel—skin cancer	3.9e-05	0.000652	CcSEcCtD
Ifosfamide—Leukopenia—Fluorouracil—skin cancer	3.89e-05	0.00065	CcSEcCtD
Ifosfamide—Confusional state—Temozolomide—skin cancer	3.88e-05	0.000648	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Dactinomycin—skin cancer	3.88e-05	0.000648	CcSEcCtD
Ifosfamide—Oedema—Temozolomide—skin cancer	3.85e-05	0.000643	CcSEcCtD
Ifosfamide—Anaphylactic shock—Temozolomide—skin cancer	3.85e-05	0.000643	CcSEcCtD
Ifosfamide—Infection—Temozolomide—skin cancer	3.82e-05	0.000639	CcSEcCtD
Ifosfamide—Nausea—Imiquimod—skin cancer	3.81e-05	0.000637	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Docetaxel—skin cancer	3.79e-05	0.000634	CcSEcCtD
Ifosfamide—Nervous system disorder—Temozolomide—skin cancer	3.77e-05	0.00063	CcSEcCtD
Ifosfamide—Thrombocytopenia—Temozolomide—skin cancer	3.77e-05	0.000629	CcSEcCtD
Ifosfamide—Convulsion—Fluorouracil—skin cancer	3.76e-05	0.000629	CcSEcCtD
Ifosfamide—Feeling abnormal—Bleomycin—skin cancer	3.76e-05	0.000628	CcSEcCtD
Ifosfamide—Agranulocytosis—Docetaxel—skin cancer	3.74e-05	0.000626	CcSEcCtD
Ifosfamide—Skin disorder—Temozolomide—skin cancer	3.74e-05	0.000624	CcSEcCtD
Ifosfamide—Hyperhidrosis—Temozolomide—skin cancer	3.72e-05	0.000622	CcSEcCtD
Ifosfamide—Myalgia—Fluorouracil—skin cancer	3.7e-05	0.000618	CcSEcCtD
Ifosfamide—Chest pain—Fluorouracil—skin cancer	3.7e-05	0.000618	CcSEcCtD
Ifosfamide—Decreased appetite—Dactinomycin—skin cancer	3.7e-05	0.000618	CcSEcCtD
Ifosfamide—Fatigue—Dactinomycin—skin cancer	3.67e-05	0.000613	CcSEcCtD
Ifosfamide—Anorexia—Temozolomide—skin cancer	3.67e-05	0.000613	CcSEcCtD
Ifosfamide—Discomfort—Fluorouracil—skin cancer	3.65e-05	0.000611	CcSEcCtD
Ifosfamide—Pain—Dactinomycin—skin cancer	3.64e-05	0.000608	CcSEcCtD
Ifosfamide—Urticaria—Bleomycin—skin cancer	3.62e-05	0.000605	CcSEcCtD
Ifosfamide—Haemoglobin—Docetaxel—skin cancer	3.62e-05	0.000605	CcSEcCtD
Ifosfamide—Body temperature increased—Bleomycin—skin cancer	3.61e-05	0.000602	CcSEcCtD
Ifosfamide—Haemorrhage—Docetaxel—skin cancer	3.6e-05	0.000602	CcSEcCtD
Ifosfamide—Hepatitis—Docetaxel—skin cancer	3.6e-05	0.000602	CcSEcCtD
Ifosfamide—Confusional state—Fluorouracil—skin cancer	3.57e-05	0.000597	CcSEcCtD
Ifosfamide—Urinary tract disorder—Docetaxel—skin cancer	3.56e-05	0.000594	CcSEcCtD
Ifosfamide—Anaphylactic shock—Fluorouracil—skin cancer	3.55e-05	0.000592	CcSEcCtD
Ifosfamide—Oedema—Fluorouracil—skin cancer	3.55e-05	0.000592	CcSEcCtD
Ifosfamide—Connective tissue disorder—Docetaxel—skin cancer	3.54e-05	0.000591	CcSEcCtD
Ifosfamide—Urethral disorder—Docetaxel—skin cancer	3.53e-05	0.00059	CcSEcCtD
Ifosfamide—Infection—Fluorouracil—skin cancer	3.52e-05	0.000588	CcSEcCtD
Ifosfamide—Feeling abnormal—Dactinomycin—skin cancer	3.51e-05	0.000586	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Temozolomide—skin cancer	3.51e-05	0.000586	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Dactinomycin—skin cancer	3.48e-05	0.000581	CcSEcCtD
Ifosfamide—Nervous system disorder—Fluorouracil—skin cancer	3.48e-05	0.000581	CcSEcCtD
Ifosfamide—Thrombocytopenia—Fluorouracil—skin cancer	3.47e-05	0.00058	CcSEcCtD
Ifosfamide—Visual impairment—Docetaxel—skin cancer	3.47e-05	0.00058	CcSEcCtD
Ifosfamide—Paraesthesia—Temozolomide—skin cancer	3.45e-05	0.000577	CcSEcCtD
Ifosfamide—Dyspnoea—Temozolomide—skin cancer	3.43e-05	0.000573	CcSEcCtD
Ifosfamide—Somnolence—Temozolomide—skin cancer	3.42e-05	0.000572	CcSEcCtD
Ifosfamide—Erythema multiforme—Docetaxel—skin cancer	3.41e-05	0.000569	CcSEcCtD
Ifosfamide—Anorexia—Fluorouracil—skin cancer	3.38e-05	0.000565	CcSEcCtD
Ifosfamide—Eye disorder—Docetaxel—skin cancer	3.37e-05	0.000562	CcSEcCtD
Ifosfamide—Abdominal pain—Dactinomycin—skin cancer	3.36e-05	0.000562	CcSEcCtD
Ifosfamide—Body temperature increased—Dactinomycin—skin cancer	3.36e-05	0.000562	CcSEcCtD
Ifosfamide—Hypersensitivity—Bleomycin—skin cancer	3.36e-05	0.000562	CcSEcCtD
Ifosfamide—Decreased appetite—Temozolomide—skin cancer	3.34e-05	0.000559	CcSEcCtD
Ifosfamide—Flushing—Docetaxel—skin cancer	3.34e-05	0.000558	CcSEcCtD
Ifosfamide—Cardiac disorder—Docetaxel—skin cancer	3.34e-05	0.000558	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Temozolomide—skin cancer	3.32e-05	0.000555	CcSEcCtD
Ifosfamide—Fatigue—Temozolomide—skin cancer	3.32e-05	0.000554	CcSEcCtD
Ifosfamide—Hypotension—Fluorouracil—skin cancer	3.31e-05	0.000554	CcSEcCtD
Ifosfamide—Constipation—Temozolomide—skin cancer	3.29e-05	0.00055	CcSEcCtD
Ifosfamide—Pain—Temozolomide—skin cancer	3.29e-05	0.00055	CcSEcCtD
Ifosfamide—Asthenia—Bleomycin—skin cancer	3.27e-05	0.000547	CcSEcCtD
Ifosfamide—Angiopathy—Docetaxel—skin cancer	3.27e-05	0.000546	CcSEcCtD
Ifosfamide—Immune system disorder—Docetaxel—skin cancer	3.25e-05	0.000544	CcSEcCtD
Ifosfamide—Mediastinal disorder—Docetaxel—skin cancer	3.25e-05	0.000542	CcSEcCtD
Ifosfamide—Chills—Docetaxel—skin cancer	3.23e-05	0.00054	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Fluorouracil—skin cancer	3.23e-05	0.00054	CcSEcCtD
Ifosfamide—Pruritus—Bleomycin—skin cancer	3.23e-05	0.000539	CcSEcCtD
Ifosfamide—Arrhythmia—Docetaxel—skin cancer	3.22e-05	0.000538	CcSEcCtD
Ifosfamide—Paraesthesia—Fluorouracil—skin cancer	3.18e-05	0.000532	CcSEcCtD
Ifosfamide—Alopecia—Docetaxel—skin cancer	3.18e-05	0.000532	CcSEcCtD
Ifosfamide—Feeling abnormal—Temozolomide—skin cancer	3.17e-05	0.00053	CcSEcCtD
Ifosfamide—Dyspnoea—Fluorouracil—skin cancer	3.16e-05	0.000528	CcSEcCtD
Ifosfamide—Mental disorder—Docetaxel—skin cancer	3.16e-05	0.000527	CcSEcCtD
Ifosfamide—Somnolence—Fluorouracil—skin cancer	3.15e-05	0.000527	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Temozolomide—skin cancer	3.15e-05	0.000526	CcSEcCtD
Ifosfamide—Malnutrition—Docetaxel—skin cancer	3.14e-05	0.000524	CcSEcCtD
Ifosfamide—Erythema—Docetaxel—skin cancer	3.14e-05	0.000524	CcSEcCtD
Ifosfamide—Hypersensitivity—Dactinomycin—skin cancer	3.13e-05	0.000524	CcSEcCtD
Ifosfamide—Decreased appetite—Fluorouracil—skin cancer	3.08e-05	0.000515	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Fluorouracil—skin cancer	3.06e-05	0.000511	CcSEcCtD
Ifosfamide—Urticaria—Temozolomide—skin cancer	3.06e-05	0.000511	CcSEcCtD
Ifosfamide—Asthenia—Dactinomycin—skin cancer	3.05e-05	0.00051	CcSEcCtD
Ifosfamide—Body temperature increased—Temozolomide—skin cancer	3.04e-05	0.000508	CcSEcCtD
Ifosfamide—Abdominal pain—Temozolomide—skin cancer	3.04e-05	0.000508	CcSEcCtD
Ifosfamide—Pain—Fluorouracil—skin cancer	3.03e-05	0.000507	CcSEcCtD
Ifosfamide—Feeling abnormal—Fluorouracil—skin cancer	2.92e-05	0.000488	CcSEcCtD
Ifosfamide—Diarrhoea—Dactinomycin—skin cancer	2.91e-05	0.000486	CcSEcCtD
Ifosfamide—Vomiting—Bleomycin—skin cancer	2.9e-05	0.000485	CcSEcCtD
Ifosfamide—Anaemia—Docetaxel—skin cancer	2.9e-05	0.000484	CcSEcCtD
Ifosfamide—Rash—Bleomycin—skin cancer	2.88e-05	0.000481	CcSEcCtD
Ifosfamide—Dermatitis—Bleomycin—skin cancer	2.87e-05	0.00048	CcSEcCtD
Ifosfamide—Hypersensitivity—Temozolomide—skin cancer	2.83e-05	0.000474	CcSEcCtD
Ifosfamide—Urticaria—Fluorouracil—skin cancer	2.82e-05	0.000471	CcSEcCtD
Ifosfamide—Leukopenia—Docetaxel—skin cancer	2.81e-05	0.000469	CcSEcCtD
Ifosfamide—Body temperature increased—Fluorouracil—skin cancer	2.8e-05	0.000468	CcSEcCtD
Ifosfamide—Palpitations—Docetaxel—skin cancer	2.77e-05	0.000463	CcSEcCtD
Ifosfamide—Asthenia—Temozolomide—skin cancer	2.76e-05	0.000461	CcSEcCtD
Ifosfamide—Cough—Docetaxel—skin cancer	2.74e-05	0.000457	CcSEcCtD
Ifosfamide—Pruritus—Temozolomide—skin cancer	2.72e-05	0.000455	CcSEcCtD
Ifosfamide—Convulsion—Docetaxel—skin cancer	2.72e-05	0.000454	CcSEcCtD
Ifosfamide—Nausea—Bleomycin—skin cancer	2.71e-05	0.000453	CcSEcCtD
Ifosfamide—Hypertension—Docetaxel—skin cancer	2.71e-05	0.000452	CcSEcCtD
Ifosfamide—Vomiting—Dactinomycin—skin cancer	2.7e-05	0.000452	CcSEcCtD
Ifosfamide—Rash—Dactinomycin—skin cancer	2.68e-05	0.000448	CcSEcCtD
Ifosfamide—Chest pain—Docetaxel—skin cancer	2.67e-05	0.000446	CcSEcCtD
Ifosfamide—Arthralgia—Docetaxel—skin cancer	2.67e-05	0.000446	CcSEcCtD
Ifosfamide—Myalgia—Docetaxel—skin cancer	2.67e-05	0.000446	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	2.65e-05	0.000443	CcSEcCtD
Ifosfamide—Diarrhoea—Temozolomide—skin cancer	2.63e-05	0.00044	CcSEcCtD
Ifosfamide—Hypersensitivity—Fluorouracil—skin cancer	2.61e-05	0.000436	CcSEcCtD
Ifosfamide—Confusional state—Docetaxel—skin cancer	2.58e-05	0.000431	CcSEcCtD
Ifosfamide—Anaphylactic shock—Docetaxel—skin cancer	2.56e-05	0.000428	CcSEcCtD
Ifosfamide—Oedema—Docetaxel—skin cancer	2.56e-05	0.000428	CcSEcCtD
Ifosfamide—Dizziness—Temozolomide—skin cancer	2.54e-05	0.000425	CcSEcCtD
Ifosfamide—Infection—Docetaxel—skin cancer	2.54e-05	0.000425	CcSEcCtD
Ifosfamide—Nausea—Dactinomycin—skin cancer	2.53e-05	0.000422	CcSEcCtD
Ifosfamide—Nervous system disorder—Docetaxel—skin cancer	2.51e-05	0.000419	CcSEcCtD
Ifosfamide—Pruritus—Fluorouracil—skin cancer	2.51e-05	0.000419	CcSEcCtD
Ifosfamide—Thrombocytopenia—Docetaxel—skin cancer	2.51e-05	0.000419	CcSEcCtD
Ifosfamide—Skin disorder—Docetaxel—skin cancer	2.49e-05	0.000415	CcSEcCtD
Ifosfamide—Vomiting—Temozolomide—skin cancer	2.45e-05	0.000409	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—skin cancer	2.44e-05	0.000408	CcSEcCtD
Ifosfamide—Rash—Temozolomide—skin cancer	2.43e-05	0.000405	CcSEcCtD
Ifosfamide—Diarrhoea—Fluorouracil—skin cancer	2.43e-05	0.000405	CcSEcCtD
Ifosfamide—Dermatitis—Temozolomide—skin cancer	2.42e-05	0.000405	CcSEcCtD
Ifosfamide—Hypotension—Docetaxel—skin cancer	2.39e-05	0.0004	CcSEcCtD
Ifosfamide—Dizziness—Fluorouracil—skin cancer	2.34e-05	0.000392	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—skin cancer	2.33e-05	0.00039	CcSEcCtD
Ifosfamide—Paraesthesia—Docetaxel—skin cancer	2.3e-05	0.000384	CcSEcCtD
Ifosfamide—Nausea—Temozolomide—skin cancer	2.29e-05	0.000382	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—skin cancer	2.28e-05	0.000381	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—skin cancer	2.27e-05	0.00038	CcSEcCtD
Ifosfamide—Vomiting—Fluorouracil—skin cancer	2.25e-05	0.000377	CcSEcCtD
Ifosfamide—Rash—Fluorouracil—skin cancer	2.24e-05	0.000373	CcSEcCtD
Ifosfamide—Dermatitis—Fluorouracil—skin cancer	2.23e-05	0.000373	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—skin cancer	2.22e-05	0.000372	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—skin cancer	2.21e-05	0.000369	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—skin cancer	2.21e-05	0.000369	CcSEcCtD
Ifosfamide—Pain—Docetaxel—skin cancer	2.19e-05	0.000366	CcSEcCtD
Ifosfamide—Constipation—Docetaxel—skin cancer	2.19e-05	0.000366	CcSEcCtD
Ifosfamide—Feeling abnormal—Docetaxel—skin cancer	2.11e-05	0.000352	CcSEcCtD
Ifosfamide—Nausea—Fluorouracil—skin cancer	2.11e-05	0.000352	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—skin cancer	2.09e-05	0.00035	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—skin cancer	2.02e-05	0.000338	CcSEcCtD
Ifosfamide—Abdominal pain—Docetaxel—skin cancer	2.02e-05	0.000338	CcSEcCtD
Ifosfamide—Hypersensitivity—Docetaxel—skin cancer	1.89e-05	0.000315	CcSEcCtD
Ifosfamide—Asthenia—Docetaxel—skin cancer	1.84e-05	0.000307	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—skin cancer	1.81e-05	0.000302	CcSEcCtD
Ifosfamide—Diarrhoea—Docetaxel—skin cancer	1.75e-05	0.000293	CcSEcCtD
Ifosfamide—Dizziness—Docetaxel—skin cancer	1.69e-05	0.000283	CcSEcCtD
Ifosfamide—Vomiting—Docetaxel—skin cancer	1.63e-05	0.000272	CcSEcCtD
Ifosfamide—Rash—Docetaxel—skin cancer	1.61e-05	0.00027	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—skin cancer	1.61e-05	0.000269	CcSEcCtD
Ifosfamide—Nausea—Docetaxel—skin cancer	1.52e-05	0.000254	CcSEcCtD
